Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Burton

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Gastrointestinal Oncology|September 12, 2017
A margin distance analysis of the impact of adjuvant chemoradiation on survival after pancreatoduodenectomy for pancreatic adenocarcinomaLee M Ocuin, Jennifer L Miller-Ocuin, Mazen S Zenati, et al.
Neurosurgery|March 20, 2026
Stereotactic Body Radiotherapy for Spinal Metastases: Outcomes and Development of a Risk Assessment Score to Predict Local Tumor ProgressionSuchet Taori, Samuel Adida, Shovan Bhatia, et al.
Radiation Oncology (London, England)|February 1, 2014
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapyZachary D Horne, David A Clump, John A Vargo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2025
Lessons Learned About Acute and Late Toxicity After Two Decades of Experience With Pancreatic SBRTSusannah G Ellsworth, Mohamed Abdelhakiem, Baher Elgohari, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Gastrointestinal Oncology|September 12, 2017
A margin distance analysis of the impact of adjuvant chemoradiation on survival after pancreatoduodenectomy for pancreatic adenocarcinomaLee M Ocuin, Jennifer L Miller-Ocuin, Mazen S Zenati, et al.
Neurosurgery|March 20, 2026
Stereotactic Body Radiotherapy for Spinal Metastases: Outcomes and Development of a Risk Assessment Score to Predict Local Tumor ProgressionSuchet Taori, Samuel Adida, Shovan Bhatia, et al.
Radiation Oncology (London, England)|February 1, 2014
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapyZachary D Horne, David A Clump, John A Vargo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2025
Lessons Learned About Acute and Late Toxicity After Two Decades of Experience With Pancreatic SBRTSusannah G Ellsworth, Mohamed Abdelhakiem, Baher Elgohari, et al.
Pageof 8